Research co-authored by RTI Health Solutions researchers will be presented at the 2019 North American Neuroendocrine Tumor Society (NANETS) Conference.
Satisfaction Survey of administration modes for Long-Acting (LA) Somatostatin Analog (SSA) therapy in patients with Neuroendocrine Tumors (NET). Darden C, Ray D, Goldstein G, Goss D, Garbinsky D, Bennett L, Price M, Thota R.
XERMELO patient registry: improvements in clinical outcomes, patients satisfaction, and weight with telotristat ethyl in the real-world. Joish VN, Price MA, Schwartz S, Fish-Steagall A, Bennett L, Darden C, Tesfaye E, Arnold K, Wason S, Lapuerta P.
Mark Price, MEd, MA, Executive Director of Surveys and Observational Studies will be attending the meeting. Contact him to set up a time to learn more about how we can help you understand the real-world use, value, and safety of your products.